From: Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome
V/V
V/F
F/F
P**
H/H
H/R
R/R
Skin toxicity grade*
Grade 1
3
9
5
10
0
Grade 2
7
8
2
Grade 3
0.2707
1
0.4198